UK gene scientist honoured with knighthood
June 17, 2013Medical Communications, Research and Development, Sales and Marketing Cancer, genes, knighthood, mike stratton, personalised
A British scientist who helped discover the BRCA breast cancer gene and paved the way for personalised medicine has been …
Catalent breaks ground on $35m controlled-release facility
June 17, 2013Manufacturing and Production Catalent
Catalent Pharma Solutions has started construction of a new facility at its site in Winchester, Kentucky, that will boost its …
No evidence of fault at Teva plant linked to drug switch death
June 14, 2013Manufacturing and Production Teva, death
France’s medicines regulator has concluded that a plant operated in the country by generic drugmaker Teva was not at fault …
Leo exaggerates Picato properties
June 14, 2013Medical Communications, Sales and Marketing ABPI, LEO Pharma, PMCPA
Leo Pharma has been censured by the PMCPA for not maintaining high standards over an advertisement that overreached itself when …
PAREXEL appoints senior VP and CFO
June 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Parexel
Biopharma services provider PAREXEL has appointed Ingo Bank to be a senior VP and chief financial officer at the firm. …
Baxter warned by FDA over repeat failings at two plants
June 14, 2013Manufacturing and Production FDA, baxter
Baxter has attracted the ire of the US Food and Drug Administration over quality failures at two sterile product manufacturing …
Iluvien gets NHS nod
June 14, 2013Sales and Marketing Iluvien, NHS, NICE, alimera
NICE is gearing up to allow Alimera Sciences’ implant Iluvien to be used on the NHS as an option to …
BASF launches online magazine
June 13, 2013Medical Communications BASF, chemicals, multimedia, online
The world’s leading chemical company BASF has launched an online version of its global magazine ‘Creating Chemistry.’ The publication which …
Orencia matches Humira
June 13, 2013Sales and Marketing AbbVie, Abbott, Humira, Orencia, RA
Bristol-Myers Squibb is hoping its biologic Orencia can grab a little more of the rheumatoid arthritis market after demonstrating non-inferiority …
Swiss comms agency archimed joins Fishawack
June 13, 2013Medical Communications archimed, fishawack
The Fishawack Group has acquired Swiss-based medical communications firm archimed in a deal that will expand both companies’ offerings. The …
‘Game-changing’ cancer database launched
June 13, 2013Medical Communications, Research and Development, Sales and Marketing Cancer, Department of Health, NHS
The Department of Health has unveiled a new system for co-ordinating cancer treatment which it hopes will save thousands of …
Paul Karpecki joins Freedom Meditech Scientific Advisory Board
June 13, 2013Manufacturing and Production, Research and Development, Sales and Marketing Freedom meditech
Medical device company Freedom Meditech has appointed Dr Paul Karpecki to its Scientific Advisory Board. Karpecki currently works in corneal …
Almac creates 229 jobs in Northern Ireland expansion
June 13, 2013Manufacturing and Production Almac, Ireland, laxative
Northern Ireland-based Almac is planning to invest almost £14 million in another expansion of its pharma development and manufacturing operation …
Pfizer wins $2.15 billion patent case
June 13, 2013Sales and Marketing Pfizer, Takeda, Teva, protonix
Pfizer and Takeda are to split $2.15 billion in damages from two generics manufacturers as a settlement for lost sales, …
NICE thumbs-up for Revolade
June 12, 2013Sales and Marketing
GlaxoSmithKline’s once-daily pill Revolade may be used to treat NHS patients who have a rare blood disorder, according to final …
Regulus names Stelios Papadopoulos as chairman
June 12, 2013Manufacturing and Production, Research and Development, Sales and Marketing Alnylam, Exelixis, Regulas
Biopharma firm Regulas Therapeutics has named Stelios Papadopoulos chairman of its Board of directors. Papadopoulos assumes the role from John …
Diabetes drug risks fuel transparency debate
June 12, 2013Research and Development, Sales and Marketing BMJ, Channel 4, all trials, diabetes, transaprency
A new investigation by Channel 4’s Dispatches and the British Medical Journal is demanding that all trial data be released …
French regulator probes Teva plant after patient death
June 12, 2013Manufacturing and Production Teva, furosemide, zopiclone
France’s medicines regulator has started an investigation into a manufacturing facility operated by generic firm Teva in the wake of …
ABPI: put more data in scorecards
June 12, 2013Sales and Marketing ABPI, NHS, scorecards
The ABPI has called on the NHS to include more new medicines in its innovation scorecard and to come up …
ABPI declares eye health services ‘unsustainable’
June 11, 2013Sales and Marketing ABPI, NHS England, POPI, eye health
The ABPI’s Pharmaceutical Ophthalmology Initiative (POPI) group has called for a major re-think in how eye services are delivered on the NHS.The …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
